Home › Prostate Cancer › Vermont › Burlington
Prostate Cancer clinical trials in Burlington, VT
4 studies for Prostate Cancer are looking for participants at sites in and around Burlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
RecruitingPhase 2
- University of Vermont Medical Center, Burlington
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- University of Vermont Medical Center, Burlington
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Burlington
- Heart Failure8 studies
- Acute Myeloid Leukemia7 studies
- Cancer (all types)6 studies
- COPD5 studies
- Breast Cancer5 studies
- Parkinson's Disease4 studies
- Non-Small Cell Lung Cancer4 studies
- Cystic Fibrosis4 studies
- Lung Diseases4 studies
- Leukemia4 studies
- Cardiovascular Disease4 studies
- Metastatic Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.